Publication | Closed Access

Synthesis and preliminary evaluation activity studies of novel 4-(aryl/heteroaryl-2-ylmethyl)-6-phenyl-2-[3-(4-substituted-piperazine-1-yl)propyl]pyridazin-3(2H)-one derivatives as anticancer agents

Medicinal ChemistryDerivative (Chemistry)HeterocyclicMedicineOrganic ChemistryAnticancer AgentsHeterocycle ChemistryPharmacology-One DerivativesPharmaceutical ChemistryDrug Discovery